Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT02050269
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Patient admitted to intensive care for less than 12 hours
* Acute circulatory failure
* Patient carrying an arterial catheter
* Informed consent obtained
* Affiliated to social security system
Exclusion Criteria:
* Administration of iohexol the week before intensive care admission
* Administration of iohexol expected within 24 hours of study entry
* Known history of cutaneous immediate or delayed allergic reaction to the injection of the product
* Indication for albumin transfusion within 24 hours of potential inclusion in the study
* Pregnancy or breastfeeding in progress
* Patient under guardianship or judicial protection known at the time of inclusion
* Withdrawal of consent
* Administration of iohexol outside the study within 24 hours after administration of iohexol in the context of the study
* Administration of intravenous albumin in the 24 hours following administration of iohexol in the context of the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02050269
Study Brief:
Protocol Section:
NCT02050269